As the leading funder of pediatric hematology-oncology research in Quebec, the Fondation Charles-Bruneau has invested $100 million since its creation. In the fall of 2025, it reaffirmed its commitment by announcing a historic $50 million investment by 2030.
Discover how these investments are shaping the future of research and making a tangible difference in the lives of children with cancer.
of determination to transform hope into cure.
of advancing science to stay ahead of cancer.
of innovation to give every child a future free from long-term effects.
marked by a remarkable rise in the recovery rate from 30% to more than 80% for certain types of cancer.
In fewer than 25 years, we have invested $40 million to support the construction, development and acquisition of leading-edge facilities for children with cancer.
Highly specialized care environments within Quebec’s university hospital centres specialized in paediatric hematology and oncology designed to ensure that every child can still be a child, even during treatment.
Laboratories where science transforms hope into new treatment protocols every day.
Advanced diagnostic and treatment tools that enable highly precise, personalized care based on the biology of each young patient.
Every cancer is unique. That is why we fund research projects that push the boundaries of what is possible.
Developing therapies tailored to each child’s genetic profile to target the disease with greater accuracy and effectiveness.
Investing in less invasive approaches that protect the growth and future of young patients.
Teaching a child’s immune system to do the work of recognizing and destroying cancer cells.
“The Fondation is the vital bridge between innovation and the patient’s bedside. Thanks to its support, we are integrating genomics into the care trajectory to achieve the highest global standards.”
A cure cannot wait. That is why the Fondation acts as a catalyst for a historic collaboration between Quebec’s four major university hospital centres specializing in paediatric oncology.
We pool the efforts of the CHU Sainte-Justine, the Montreal Children’s Hospital, the CHU de Québec-Université Laval, and the Santé Québec Estrie – CHUS.
By fostering collaboration between institutions, we allow leading experts to combine their discoveries.
No matter where a child receives treatment, they benefit from the collective intelligence of all researchers across the province.
“Thanks to the Fondation, every child receives outstanding care throughout Quebec and has access to the best research protocols in the province.”
Because walls do not heal without the minds behind them, we support the next generation of scientists so that knowledge can move at the speed of innovation.
Since 2017, we have supported the career development of approximately 30 exceptional students.
These scholarship recipients are the architects of personalized approaches that will save the 20% of children whose cancers are still resistant to treatment.
“The Foundation’s contribution is transforming the way we provide care throughout Quebec. Thanks to these scholarships, we attract top talent that ensures a strong future for paediatric oncology.”
Although remarkable progress has been achieved, the challenge has not yet been met. We are closer than ever, but the final sprint toward a cancer-free childhood requires the greatest precision.
It is to achieve this decisive milestone that the Fondation made a historic commitment in the fall of 2025 to invest $50 million by 2030 in research projects and platforms that will transform the treatments offered to children with cancer.
By taking research to new heights, we are accelerating the pace of progress to overcome treatment-resistant cancers and offer every survivor a life free of after-effects and complications.
“By bringing together Quebec’s leading researchers, the Fondation enables us to offer hope of a cure to those whose disease is still resistant to treatments. Together, we are taking great strides toward eradication.”